Literature DB >> 27787689

Hyposensitivity of peripheral α-adrenoceptors in respiratordependent amyotrophic lateral sclerosis assessed by intravenous norepinephrine infusion.

T Shimizu1, H Hayashi2, M Hayashi1, S Kato1, H Tanabe1.   

Abstract

Intravenous norepinephrine infusion test was performed in eight patients with amyotrophic lateral sclerosis (ALS) supported by respirators and nine control subjects, to examine α-adrenoceptor function of peripheral resistant blood vessels. Baseline plasma norepinephrine concentrations in ALS patients were significantly higher than those in control subjects, indicating basal sympathetic hyperactivity (normal 218.2 ± 59.7 pg/ml; ALS 450.0 ± 288.4 pg/ml). The stimulus-response curves in the patients were similar to those in control subjects, and there were no significant differences between mean gains of the stimulus-response curves in both groups (normal 18.7 ± 5.5; ALS 15.2 ± 11.2). However, three ALS patients, two of whom had circulatory fluctuation and sympathetic hyperactivity, revealed lower gain levels than the mean minus 2 SD in control subjects (4.7, 1.1 and 3.7). This indicates hyposensitivity or down-regulation of the α-adrenoceptor function of peripheral blood vessels in these ALS patients. For early detection of sympathetic hyperactivity and prediction of circulatory collapse, it would be useful to measure the plasma norepinephrine concentration and the gain of the norepinephrine infusion curve in respirator-dependent ALS patients.

Entities:  

Keywords:  adrenoceptors; amyotrophic lateral sclerosis; circulatory collapse; down-regulation; norepinephrine; sympathetic hyperactivity

Year:  1995        PMID: 27787689     DOI: 10.1007/BF01826200

Source DB:  PubMed          Journal:  Clin Auton Res        ISSN: 0959-9851            Impact factor:   4.435


  12 in total

1.  Behavioral changes in cold-stressed mice related to a central calcium-dependent-catecholamine synthesizing system.

Authors:  D Sutoo; K Akiyama; H Takita
Journal:  Pharmacol Biochem Behav       Date:  1991-10       Impact factor: 3.533

Review 2.  Neural mechanisms involved in cardiovascular control during affective behaviour.

Authors:  K M Spyer
Journal:  Trends Neurosci       Date:  1989-12       Impact factor: 13.837

3.  Alteration in autonomic function and cardiovascular regulation in amyotrophic lateral sclerosis.

Authors:  K Chida; S Sakamaki; T Takasu
Journal:  J Neurol       Date:  1989-03       Impact factor: 4.849

4.  Microneurographic analysis of muscle sympathetic nerve activity in amyotrophic lateral sclerosis.

Authors:  K Shindo; S Tsunoda; Z Shiozawa
Journal:  Clin Auton Res       Date:  1993-04       Impact factor: 4.435

5.  Autonomic function in amyotrophic lateral sclerosis: a study of cardiovascular responses.

Authors:  C Sachs; S Conradi; L Kaijser
Journal:  Acta Neurol Scand       Date:  1985-05       Impact factor: 3.209

6.  Letter: Amyotrophic lateral sclerosis and autonomic nervous system.

Authors:  M Jokelainen; J Palo
Journal:  Lancet       Date:  1976-06-05       Impact factor: 79.321

7.  Pharmacologic distinction of different orthostatic hypotension syndromes.

Authors:  R J Polinsky; I J Kopin; M H Ebert; V Weise
Journal:  Neurology       Date:  1981-01       Impact factor: 9.910

8.  Amyotrophic lateral sclerosis patients living beyond respiratory failure.

Authors:  H Hayashi; S Kato; A Kawada
Journal:  J Neurol Sci       Date:  1991-09       Impact factor: 3.181

9.  Sympathetic iris function in amyotrophic lateral sclerosis.

Authors:  A Bogucki; R Salvesen
Journal:  J Neurol       Date:  1987-04       Impact factor: 4.849

10.  Norepinephrine and gamma-aminobutyric acid in amyotrophic lateral sclerosis.

Authors:  M G Ziegler; B R Brooks; C R Lake; J H Wood; S J Enna
Journal:  Neurology       Date:  1980-01       Impact factor: 9.910

View more
  1 in total

1.  Reliability of autonomic activations as surrogates of cortical arousals in ventilated patients affected by amyotrophic lateral sclerosis.

Authors:  Grazia Crescimanno; Francesca Greco; Salvatore Arrisicato; Oreste Marrone
Journal:  Sleep Breath       Date:  2018-07-24       Impact factor: 2.816

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.